Indaptus Therapeutics Inc...

NASDAQ: INDP · Real-Time Price · USD
7.58
-0.23 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
7.30
-3.69%
After-hours: Aug 15, 2025, 05:43 PM EDT

Indaptus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.47K 1.47K 1.47K 1.93K 1.93K 1.93K 1.93K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 735.00 1.05K 1.38K 1.7K 1.28K 1.28K 1.36K 1.57K 1.78K 2K 1.6K 7.39M 11.56M 11.56M 11.56M 4.18M
Gross Profit
735.00 735.00 0.00 873.00 552.00 230.00 644.00 -1.28K -1.36K -1.57K -1.78K -2K -1.6K -7.39M -11.56M -11.56M -11.56M -4.18M
Operating Income
-16.34M -16M -15.37M -15.37M -16.48M -15.87M -16.38M -16.29M -15.59M -15.96M -14.91M -14.04M -13.86M -17.37M -14.58M -12.13M -10.31M -5.83M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 827.00 827.00 827.00 827.00 3.68K 3.68K
Pretax Income
-16.96M -15.75M -15.02M -14.89M -15.75M -14.98M -15.42M -15.08M -14.62M -15.21M -14.32M -13.88M -13.78M -17.37M -14.61M -12.17M -10.34M -5.83M
Net Income
-16.96M -15.75M -15.02M -14.89M -15.75M -14.98M -15.22M -14.44M -13.9M -14.49M -13.77M -13.76M -13.75M -17.34M -14.63M -12.18M -10.36M -5.87M
Selling & General & Admin
7.42M 7.52M 8.11M 8.57M 8.91M 8.53M 8.76M 8.79M 8.71M 9.06M 8.59M 8.68M 9.41M 9.44M 7.46M 5.6M 3.12M 2.37M
Research & Development
8.92M 8.47M 7.25M 6.81M 7.57M 7.33M 7.62M 7.5M 6.88M 6.91M 6.32M 5.36M 4.45M 4.75M 3.94M 3.35M 4M 3.47M
Other Expenses
n/a n/a -638 -638 -638 -638 n/a n/a n/a 33.76K 33.76K 33.76K 34.59K 827.00 2.38K 2.38K 5.23K 5.23K
Operating Expenses
16.34M 16M 15.37M 15.37M 16.48M 15.87M 16.38M 16.29M 15.59M 15.96M 14.91M 14.04M 13.86M 14.18M 11.39M 8.94M 7.12M 5.83M
Interest Expense
n/a n/a n/a 201.93K 201.93K 201.93K 201.93K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
11.89M 16M 15.37M 15.37M 16.48M 15.87M 16.38M 16.29M 15.59M 15.96M 14.91M 14.04M 13.86M 14.18M 11.39M 8.94M 7.12M 5.83M
Income Tax Expense
-4 -4 -4 n/a n/a n/a -201.93K -633.17K -719.36K -719.36K -554.35K -136.1K -49.92K -36.92K n/a 13K 13K 46K
Shares Outstanding (Basic)
574.92K 9.36M 9.36M 9.51M 8.54M 8.44M 8.4M 8.4M 8.4M 8.4M 8.27M 8.26M 8.26M 8.26M 4.09M 4.18M 5.41M 5.41M
Shares Outstanding (Diluted)
574.92K 9.36M 9.36M 9.51M 8.54M 8.44M 8.4M 8.4M 8.4M 8.4M 8.27M 8.26M 8.26M 8.26M 4.09M 4.18M 5.41M 5.41M
EPS (Basic)
-10.27 -1.65 -1.62 -1.72 -1.87 -1.79 -1.82 -1.73 -1.67 -1.74 -1.66 -2.07 -2.47 -3.38 -3.09 -2.43 -1.91 -1.09
EPS (Diluted)
-10.27 -1.65 -1.62 -1.72 -1.87 -1.79 -1.82 -1.73 -1.67 -1.74 -1.66 -2.07 -2.47 -3.38 -3.09 -2.43 -1.91 -1.09
EBITDA
-16.34M -16M -15.37M -15.37M -16.48M -15.86M -16.38M -16.28M -15.59M -15.96M -14.91M -14.04M -13.86M -10.52M -7.73M -5.28M -3.46M -5.52M
EBIT
-11.89M -16M -15.37M -15.37M -16.48M -15.87M -16.38M -16.29M -15.59M -15.96M -14.91M -14.04M -13.86M -10.52M -7.73M -5.28M -3.46M -5.83M
Depreciation & Amortization
n/a n/a 735.00 1.05K 1.38K 1.7K 1.28K 1.28K 1.36K 1.57K 1.78K 2K -1.18M -524.06K 1.4K 1.08K 567.85K -83.94K